渝開發(000514.SZ)競得重慶北碚區一幅地塊 簽定國有建設用地使用權出讓合同
格隆匯4月1日丨渝開發(000514.SZ)公佈,2020年1月20日,公司與重慶聯合產權交易所集團股份有限公司簽定了《國有建設用地使用權成交確認書》,確認公司競得重慶市北碚區蔡家組團R標準分區R24-4/05、R25-1/04、R26-1-1/05、R26-1-2/05號宗地國有建設用地使用權。該宗地土地出讓面積94911平方米,成交單價為每平方米人民幣7081元,成交總價為人民幣6.72億元。2020年4月1日,公司收到了與重慶市規劃和自然資源局簽署的《國有建設用地使用權出讓合同》。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.